Page 107 - Read Online

to establish a connection between neutofils and molecular treatments for brain metastases. Oncology 2015;29:250-7.
cocrystals through interaction of ICAM-1 protein and β2 5. Friedl P, Alexander S. Cancer invasion and the microenvironment:
integrin. [112] Subsequently, the neutrophil-melanoma cell plasticity and reciprocity. Cell 2011;147:992-1009.
complex binds to endothelial cells of capillaries to promote 6. Langley RR, Fidler IJ. The seed and soil hypothesis revisited--the
role of tumor-stroma interactions in metastasis to different organs. Int
brain tissue invasion and metastasis growth. J Cancer 2011;128:2527-35.
7. Saitoh M. Epithelial-mesenchymal transition is regulated at post-
Neoangiogenesis, prompted by VEGF release and increase transcriptional levels by transforming growth factor-β signaling
in levels of HIF-1a, is another necessary step for the during tumor progression. Cancer Sci 2015;106:481-8.
tumor growth that regulates tumor cell-microenvironment 8. Lindsey S, Langhans SA. Crosstalk of Oncogenic Signaling Pathways
interactions. [112] during Epithelial Mesenchymal Transition. Front Oncol 2014;4:358.
9. Pasquier J, Abu-Kaoud N, Al Thani H, Rafii A. Epithelial to
Finally, in the brain, astrocytes forming and surrounding the Mesenchymal Transition in a Clinical Perspective. J Oncol
2015;2015:792182.
tumoral niche may play a protective role towards the tumor 10. Mori S, Kodaira M, Ito A, Okazaki M, Kawaguchi N, Hamada Y,
cells growth, including melanoma BM, by priming reactive Takada Y, Matsuura N. Enhanced expression of integrin αvβ3
astrocytosis or protecting tumor cells from cytotoxicity induced by TGF-β is equired for the enhancing effect of Fibroblast
induced by chemotherapeutic drugs. [113] Growth Factor 1 (FGF1) in TGF-β-induced Epithelial-Mesenchymal
Transition (EMT) in mammary epithelial cells. PLoS One
CONCLUSION 2015;10:e0137486.
11. Li W, Zhang B, Li H, Zhao C, Zhong Y, Sun J, Lv S. TGF β1 mediates
epithelial mesenchymal transition via β6 integrin signaling pathway
The emerging picture depicted here appears quite in breast cancer. Cancer Invest 2014;32:409-15.
complicated and the genes, with the related cellular 12. Parvani JG, Galliher-Beckley AJ, Schiemann BJ, Schiemann WP.
mechanisms, that have been found to be involved in Targeted inactivation of β1 integrin induces β3 integrin switching,
BM carry out a number of different but still interrelated which drives breast cancer metastasis by TGF-β. Mol Biol Cell
functions. In addition, a plethora of different cell types 2013;24:3449-59.
like platelets, leukocytes, endothelial cells and astrocytes 13. Panzeri S, Zanella S, Arosio D, Vahdati L, Dal Corso A, Pignataro L,
Paolillo M, Schinelli S, Belvisi L, Gennari C, Piarulli U. Cyclic isoDGR
cooperate all together to sustain the survival of metastatic and RGD peptidomimetics containing bifunctional diketopiperazine
cells in the blood flow and in the brain parenchyma. scaffolds are integrin antagonists. Chemistry 2015;21:6265-71.
14. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams
However, although the intrinsic complexity of BM appears ED, Thompson EW. Epithelial--mesenchymal and mesenchymal-
to be a daunting task, recent findings may boost the efforts -epithelial transitions in carcinoma progression. J Cell Physiol
in the field. The development and refinement of existing 2007;213:374-83.
in vitro three-dimension models of BBB, traditionally 15. Labelle M, Begum S, Hynes RO. Direct signaling between platelets
employed in the screening of drugs or molecule designed and cancer cells induces an epithelial-mesenchymal-like transition
and promotes metastasis. Cancer Cell 2011;20:576-90.
to cross the BBB, could be used as a novel approach to 16. Tang YN, Ding WQ, Guo XJ, Yuan XW, Wang DM, Song JG.
investigate the genotype and phenotype of cancer cells that Epigenetic regulation of Smad2 and Smad3 by profilin-2 promotes
migrate through artifi cial BBBs. [114,115] lung cancer growth and metastasis. Nat Commun 2015; 10;6:8230.
17. Zhang L, Zhang J, Ma Y, Chen J, Dong B, Zhao W, Wang X, Zheng
Also, the previous mentioned breakthrough discovery of Q, Fang F, Yang Y. Testicular orphan receptor 4 (TR4) is a marker
the presence of lymphatic vessels in the brain could open for metastasis and poor prognosis in non-small cell lung cancer that
an avenue of cutting edge experimental approaches in the drives the EMT phenotype. Lung Cancer 2015;89:320-8.
study of CTCs and BM. 18. Kong FF, Qu ZQ, Yuan HH, Wang JY, Zhao M, Guo YH, Shi J, Gong
XD, Zhu YL, Liu F, Zhang WY, Jiang B. Overexpression of FOXM1
is associated with EMT and is a predictor of poor prognosis in non-
Financial support and sponsorship small cell lung cancer. Oncol Rep 2014;31:2660-8.
Nil. 19. Okabe H, Mima K, Saito S, Hayashi H, Imai K, Nitta H, Hashimoto
D, Chikamoto A, Ishiko T, Beppu T, Baba H. Epithelial-mesenchymal
Conflicts of interest transition in gastroenterological cancer. J Canc Met Treat 2015;1:183-9.
There are no conflicts of interest. 20. Meng F, Wu G. The rejuvenated scenario of epithelial-mesenchymal
transition (EMT) and cancer metastasis. Cancer Metastasis Rev
2012;31:455-67.
REFERENCES 21. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RHA,
Cuppen E. Phylogenetic shadowing and computational identification
1. Gavrilovic IT, Posner JB. Brain metastases: epidemiology and of human microRNA genes. Cell 2005;120: 21-4.
pathophysiology. J Neurooncol 2005;75:5-14. 22. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM. MicroRNA
2. Kondziolka D, Shin SM, Brunswick A, Kim I, Silverman JS. The expression and function in cancer. Trends Mol Med 2006;12:580-7.
biology of radiosurgery and its clinical applications for brain tumors. 23. Leung AK. The Whereabouts of microRNA Actions Cytoplasm and
Neuro Oncol 2015;17:29-44. Beyond. Trends Cell Biol 2015;25:601-10.
3. Nayak L, Lee EQ, Wen PY. Epidemiology of brain metastases. Curr 24. Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes
Oncol Rep 2012;14:48-54. and tumor suppressors. Dev Biol 2007;302:1-12.
4. Ba JL, Jandial R, Nesbit A, Badie B, Chen M. Current and emerging 25. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri

Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ March 11, 2016 ¦ 97